Antonio Saldana de la Rosa
General Practice · San Juan, PRNPI 1386640019
Payments from drug & device makers
Across 130 payments — averaging $32.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Sanofi-aventis U.S. LLC$397
- Pfizer Pharmaceuticals LLC$350
- PBG Puerto Rico LLC$166
- Lilly USA, LLC$98
- plus $320 from 9 others
What the payments were for
- Food & beverage$4,07997%
- Education$822%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 63 | $1,833 |
| Boehringer Ingelheim | 18 | $1,056 |
| Sanofi-aventis U.S. LLC | 18 | $397 |
| Pfizer Pharmaceuticals LLC | 7 | $350 |
| PBG Puerto Rico LLC | 8 | $166 |
| Lilly USA, LLC | 3 | $98 |
| Mannkind Corporation | 1 | $59 |
| E.r. Squibb & Sons, L.L.C. | 2 | $50 |
| GSK | 2 | $50 |
| Johnson & Johnson | 2 | $49 |
| Merck | 2 | $42 |
| KCI USA, Inc. | 1 | $38 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $17 |
| Mylan LLC | 1 | $11 |
| Pfizer | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,221 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 111 | $115,842 |
| TradjentaLinagliptin | 88 | $91,744 |
| FarxigaDapagliflozin Propanediol | 79 | $82,344 |
| EliquisApixaban | 91 | $72,666 |
| JanuviaSitagliptin Phosphate | 64 | $67,909 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 91 | $57,667 |
| GlyxambiEmpagliflozin/Linagliptin | 54 | $50,092 |
| Jentadueto XrLinagliptin/Metformin Hcl | 50 | $45,709 |
| Xigduo XrDapaglifloz Propaned/Metformin | 40 | $45,277 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 62 | $44,104 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $36,586 |
| JardianceEmpagliflozin | 32 | $36,533 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 39 | $33,626 |
| SynthroidLevothyroxine Sodium | 307 | $31,901 |
| XareltoRivaroxaban | 42 | $30,039 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTrijardy Xr, Tradjenta, Glyxambi, Jentadueto Xr, Synjardy Xr | $1,056 | $384,024397 claims |
| MerckJanuvia, Janumet Xr, Janumet | $42 | $111,317114 claims |
| AstraZenecaFarxiga, Lokelma | $1,833 | $94,09590 claims |
| PfizerEliquis, Paxlovid | $5 | $78,268104 claims |
| GSKTrelegy Ellipta | $50 | $36,58651 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $397 | $30,508188 claims |
| Johnson & JohnsonXarelto | $49 | $30,03942 claims |
| Lilly USA, LLCHumalog | $98 | $2,72632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Other general practice in San Juan
- Gregorio Cortes-MaisonetSan Juan$12.8M
- Orvil MartinezSan Juan$211K
- Yudit Brito PequeroSan Juan$156K
- Miguel Sosa PadillaSan Juan$155K
- Vivian Tamayo AgraitSan Juan$96K
- William E TorresSan Juan$86K
- Roberto Unda GomezSan Juan$79K
- Eduardo Miralles AlonsoSan Juan$71K
- Victor PalmerSan Juan$21K
- Jose Davila SanchezSan Juan$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.